Model strategy & challenge
Define the target decision, success criteria and constraints, then assess whether the incumbent approach remains calibrated, stable and useful.
Compare, calibrate and govern models that improve insurance decisions without sacrificing transparency or control.
Model choice follows evidence
Greater complexity does not automatically create greater value. The appropriate model depends on the business question, data, performance evidence, operational constraints and the level of explanation and governance the decision requires.
Arocha & Associates combines traditional actuarial methods with modern machine learning to develop and challenge models for pricing, underwriting, claims, risk segmentation and other insurance applications.
Engagements may start with an incumbent-model diagnostic, a challenger comparison or the development of a controlled model from data through implementation.
Core support
Define the target decision, success criteria and constraints, then assess whether the incumbent approach remains calibrated, stable and useful.
Develop and compare GLMs, gradient-boosting models, neural networks or hybrid approaches using consistent data, metrics and validation evidence.
Translate model output into an operating decision with documentation, human oversight, implementation controls, performance monitoring and recalibration.
Evidence before selection
Applied example: explore the interactive GLM–FFNN model comparison demonstrator.
A decision-led modelling cycle
The work separates genuine model improvement from apparent gains caused by data, validation design or inconsistent comparison.
Define the decision, target, data, constraints and business success measures.
Build or diagnose a transparent benchmark and verify data and evaluation design.
Compare alternatives across performance, stability, explanation and operating cost.
Select, document, implement and monitor the model appropriate for the use.
Typical outcomes
Start with the modelling decision
We can diagnose the incumbent model, build a credible challenger and translate the evidence into a practical recommendation.